Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.3 ALLIANCE PHARMA PLC

17 Apr 2025 13:22

RNS Number : 5088F
Barclays PLC
17 April 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ALLIANCE PHARMA PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Apr 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

5,741,923

1.06%

1,956,258

0.36%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

1,063,873

0.20%

5,741,834

1.06%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

6,805,796

1.26%

7,698,092

1.42%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

39,648

0.6420 GBP

1p ordinary

Purchase

14,994

0.6430 GBP

1p ordinary

Sale

43,918

0.6424 GBP

1p ordinary

Sale

35,540

0.6420 GBP

1p ordinary

Sale

14,951

0.6419 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Decreasing Short

12,863

0.6419 GBP

1p ordinary

SWAP

Decreasing Short

23,698

0.6420 GBP

1p ordinary

SWAP

Decreasing Short

42,076

0.6424 GBP

1p ordinary

SWAP

Increasing Short

25,538

0.6420 GBP

1p ordinary

SWAP

Increasing Short

14,994

0.6430 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Apr 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETIRMBTMTABBBA
Date   Source Headline
23rd Nov 20165:45 pmRNSExercise of Share Options
17th Nov 20165:05 pmRNSNotification of Major Interest in Shares
17th Nov 201610:40 amRNSExercise of Share Options
28th Oct 20165:13 pmRNSShare Options
28th Oct 20167:00 amRNSAppointment of Deputy CEO
5th Oct 20166:00 pmRNSExercise of Share Options
23rd Sep 20167:01 amRNSExercise of Share Options
23rd Sep 20167:00 amRNSDirector Dealings
14th Sep 20167:00 amRNSInterim Results
13th Sep 20167:00 amRNSNew Agreement for Diclectin in Europe
18th Aug 20167:00 amRNSInterim Results Analyst Meeting - Change of Time
8th Aug 20165:00 pmRNSExercise of Share Options
2nd Aug 20167:00 amRNSNotification of Interim Results
26th Jul 20167:00 amRNSExercise of Share Options
19th Jul 20167:00 amRNSHalf Year Trading Update
12th Jul 20167:00 amRNSNotification of Half Year Trading Update
25th May 201611:15 amRNSResult of AGM
25th May 20167:00 amRNSAGM Statement
24th May 20167:00 amRNSExercise of Share Options
5th May 20161:30 pmRNSDirector Shareholding
3rd May 20167:00 amRNSExercise of Share Options
28th Apr 20167:00 amRNSAnnual Report and AGM Notice
7th Apr 20167:00 amRNSPreliminary Results
18th Mar 20167:00 amRNSNotification of Preliminary Results
3rd Mar 20167:00 amRNSHardman & Co Research Report
5th Feb 20163:57 pmRNSExercise of Share Options
22nd Jan 20163:45 pmRNSExercise of Share Options
21st Jan 20167:00 amRNSPre-Close Trading Update
12th Jan 20162:34 pmRNSNotification of Major Interest in Shares
7th Jan 20161:56 pmRNSNotification of Major Interest in Shares
23rd Dec 201512:02 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Dec 20154:40 pmRNSDirector Shareholding
18th Dec 20155:15 pmRNSNotification of Major Interest in Shares
18th Dec 20154:20 pmRNSNotification of Major Interest in Shares
18th Dec 20153:54 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
17th Dec 20153:39 pmRNSNotification of Major Interest in Shares
17th Dec 20153:13 pmRNSNotification of Major Interest in Shares
17th Dec 20159:00 amRNSCompletion of Acquisition and Placing
14th Dec 20154:00 pmRNSResult of General Meeting
8th Dec 20155:41 pmRNSNotification of Major Interest in Shares
7th Dec 20157:00 amRNSShare Options
3rd Dec 20152:03 pmRNSPlacing Update: Exercise of Broker's Option
2nd Dec 20158:00 amRNSSchedule 1 - Alliance Pharma Plc
26th Nov 20154:35 pmRNSInterim Dividend Timetable
26th Nov 20157:00 amRNSProposed Acquisition
23rd Nov 20154:00 pmRNSDirectorate Change
5th Nov 20157:00 amRNSSettlement Agreement
10th Sep 20157:00 amRNSInterim Dividend Timetable - Record Date
9th Sep 20157:00 amRNSInterim Results
2nd Sep 20156:01 pmRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.